Vaseem Mahboob sold $680k of KMTS
Chief Financial Officer at KESTRA MEDICAL TECHNOLOGIES, LTD.. 26,287 shares at an average of $25.88, traded Aug 7, 2026, filed Aug 11, 2026.
Score components
- +22RoleCFO
- +21Trade size$680k at market
- +10Share of holdings soldSold 30% of holdings
- +15Cluster5 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-345169, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | SOpen-market sale Common Shares10b5-1 | -25,787 | $25.87 | $667k | 61,109 | Aug 11, 2026 |
| Aug 7, 2026 | SOpen-market sale Common Shares10b5-1 | -500 | $26.33 | $13k | 60,609 | Aug 11, 2026 |
Related signals
Other insiders at KESTRA MEDICAL TECHNOLOGIES, LTD. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | KESTRA MEDICAL TECHNOLOGIES, LTD. | Raymond W Cohen director | $98k 3,330 shares | -6% | |
| 45Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Elizabeth Kwo director | $97k 4,010 shares | -22% | |
| 51Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Conor Hanley director | $144k 5,694 shares | -48% | |
| 50Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Jeffrey Lawrence Schwartz director, owner | $98k 3,890 shares | -36% | |
| 40Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Mary Kay Ladone director | $98k 3,908 shares | -9% | |
| 48Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Kevin C Reilly director | $74k 2,932 shares | -35% | |
| 26Weak | KESTRA MEDICAL TECHNOLOGIES, LTD. | Brian Daniel Webster See Remarks | $412k 15,000 shares | -3% | |
| 41Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Alfred J Ford Jr Chief Commercial Officer | $151k 6,275 shares | -6% | |
| 55Moderate | KESTRA MEDICAL TECHNOLOGIES, LTD. | Brian Daniel Webster See Remarks | $1.3M 51,900 shares | -10% | |
| 39Weak | KESTRA MEDICAL TECHNOLOGIES, LTD. | Traci S Umberger See Remarks | $86k 3,580 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.